Clinical trial
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either…
NCT00260208 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00260208 |
|---|---|
| Title | Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus |
| Official title | A Multicenter, Randomized, Open-label Study to Compare the Development of Liver Fibrosis at 12 Months After Transplantation for Hepatitis C Cirrhosis in Patients Receiving Either Cyclosporine Microemulsion or Tacrolimus |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplant, Hepatitis C |
| Intervention type | Drug |
| Interventions | Cyclosporine A, Tacrolimus |
| Enrollment | 361 |
| Start date | Jan 1, 2006 |
| Primary completion | Sep 1, 2010 |
| First posted | Dec 1, 2005 |
| Last update posted | Dec 6, 2011 |
| Countries | Switzerland, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: